In the phase 1/2 INSPIRE DUCHENNE trial, interim data showed an average microdystrophin expression of 110% among participants ...

A student in South Korea proved that nothing can get in the way of him getting his master’s degree. Jang Ik-sun, defied all ...

Now through the end of March, people can help raise funds for ALS and other rare neuromuscular diseases at places across the ...

The leading charity for more than 110,000 children and adults in the UK living with one of over 60 muscle wasting and ...

A South Korean student has overcome incredible challenges to earn a master’s degree despite living with a severe form of muscular dystrophy. This condition, which weakens and deteriorates muscles over ...

In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

Entrada Therapeutics can plough on with the development of its Duchenne muscular dystrophy (DMD) therapy, ENTR-601-44, now ...

Despite being almost completely paralysed, a South Korean student completed his master’s degree using eye-tracking technology.

He wrote his thesis using an eye-tracking mouse, typing one letter at a time by blinking. Read more at straitstimes.com.

Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy candidate (DMD) back on track after the FDA ...

Reflecting on his sudden hospitalization last year, columnist Patrick Moeschen emphasizes the need to create an emergency medical plan.

Entrada Therapeutics gains FDA clearance for its Phase 1b ELEVATE-44-102 study, evaluating ENTR-601-44 in adult Duchenne ...